Zhitong Finance App News, Tong Ren Tang Sinopharm (03613) announced that its subsidiary, Beijing Tong Ren Tang (Macau) Co., Ltd. (“Tong Ren Tang Macau Company”), received the “Proprietary Chinese Medicine Registration Certificate” issued by the Drug Administration of the Macau Special Administrative Region Government and allowed the use of “Shi Lintong Granules [Tong Ren Tang]”, “Liver Relief Pills [Tong Ren Tang]”, “Tongrentang”, “Nourishing Fitness Pills [Tong Ren Tang]”, “Tongren Tang” “Champion Pills [Tong Ren Tang]” (hereinafter collectively referred to as “pharmaceuticals”) in the Macau Special Administrative Region of the People's Republic of China ( (Macau) For sale.

The registered holder of the above drug is Tong Ren Tang Macau Company. As of the date of this announcement, the total registration fees associated with the production of the above drugs by the Company were approximately HK$50,000 (the amount has not been audited). The above medicines have not yet been sold in Macau.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.